Heart disease and stroke statistics—2023 update: a report from the American Heart Association

CW Tsao, AW Aday, ZI Almarzooq, CAM Anderson… - Circulation, 2023 - Am Heart Assoc
Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …

2024 heart disease and stroke statistics: a report of US and global data from the American Heart Association

SS Martin, AW Aday, ZI Almarzooq, CAM Anderson… - Circulation, 2024 - Am Heart Assoc
BACKGROUND: The American Heart Association (AHA), in conjunction with the National
Institutes of Health, annually reports the most up-to-date statistics related to heart disease …

Comprehensive management of cardiovascular risk factors for adults with type 2 diabetes: a scientific statement from the American Heart Association

JJ Joseph, P Deedwania, T Acharya, D Aguilar… - Circulation, 2022 - Am Heart Assoc
Cardiovascular disease remains the leading cause of death in patients with diabetes.
Cardiovascular disease in diabetes is multifactorial, and control of the cardiovascular risk …

Managing Atherosclerotic Cardiovascular Risk in Young Adults: JACC State-of-the-Art Review

NJ Stone, SC Smith Jr, CE Orringer, NA Rigotti… - Journal of the American …, 2022 - jacc.org
There is a need to identify high-risk features that predict early-onset atherosclerotic
cardiovascular disease (ASCVD). The authors provide insights to help clinicians identify and …

Molecular mechanisms of vascular health: insights from vascular aging and calcification

NR Sutton, R Malhotra, C St. Hilaire… - … , and vascular biology, 2023 - Am Heart Assoc
Cardiovascular disease is the most common cause of death worldwide, especially beyond
the age of 65 years, with the vast majority of morbidity and mortality due to myocardial …

The dawn of a new era of targeted lipid-lowering therapies

L Tokgözoğlu, P Libby - European heart journal, 2022 - academic.oup.com
Lipid risk factors for cardiovascular disease depend in part on lifestyle, but optimum control
of lipids often demands additional measures. Low-density lipoprotein (LDL) doubtless …

Assessment of cardiovascular disease risk: a 2022 update

E Goldsborough, N Osuji… - … and Metabolism Clinics, 2022 - endo.theclinics.com
Cardiovascular diseases (CVDs) are the leading cause of death worldwide, with
atherosclerotic cardiovascular disease (ASCVD) being the dominant cause of total CVD …

Major global coronary artery calcium guidelines

IS Golub, OG Termeie, S Kristo, LP Schroeder… - Cardiovascular …, 2023 - jacc.org
This review summarizes the framework behind global guidelines of coronary artery calcium
(CAC) in atherosclerotic cardiovascular disease risk assessment, for applications in both the …

2022 ACC expert consensus decision pathway on the role of nonstatin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular …

Writing Committee, DM Lloyd-Jones, PB Morris… - Journal of the American …, 2022 - jacc.org
The American College of Cardiology (ACC) has a long history of developing documents (eg,
decision pathways, health policy statements, appropriate use criteria) to provide members …

[图书][B] Braunwald's heart disease-E-book: a textbook of cardiovascular medicine

P Libby - 2021 - books.google.com
Current, comprehensive, and evidence-based Braunwald's Heart Disease remains the most
trusted reference in the field and the leading source of reliable cardiology information for …